Civic AI
Procurement intelligence
Federal contract award
PREVENT PRECLINICAL DRUG DEVELOPMENT PROGRAM: PRECLINICAL EFFICACY AND INTERMEDIATE BIOMARKERS TASK ORDER TITLE: SULFORAPHANE FOR THE PREVENTION OF MALIGNANT MESOTHELIOMA
THE INSTITUTE FOR CANCER RESEARCH · Department of Health and Human Services
- Value
- $1,199,274
- Start
- May 3, 2023
- End
- May 2, 2027
- Action date
- Apr 7, 2026
- PIID
- 75N91023F00003
- Status
- active
- NAICS
- 541714 · RESEARCH AND DEVELOPMENT IN BIOTECHNOLOGY (EXCEPT NANOBIOTECHNOLOGY)
- Place of performance
- PHILADELPHIA, PA
- Award type
- DELIVERY ORDER
Description
PREVENT PRECLINICAL DRUG DEVELOPMENT PROGRAM: PRECLINICAL EFFICACY AND INTERMEDIATE BIOMARKERS TASK ORDER TITLE: SULFORAPHANE FOR THE PREVENTION OF MALIGNANT MESOTHELIOMA
Need modifications, related awards, and vendor peers? Open the full award workspace.